call +44 (0) 20 7060 7474
or email us
Search Results for
"Poniard Pharmaceuticals Inc"
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
previous
Title  | Date  | Price | Relevance  |
|---|---|---|---|
| Poniard Pharmaceuticals Inc -Detailed Product Pipeline Product Code: LSA03338 | Feb 2008 | £375.00 | 100 % |
| Poniard Pharmaceuticals Inc -Therapeutic Competitors Product Code: LSA02791 | Feb 2008 | £175.00 | 100 % |
| Poniard Pharmaceuticals, Inc. -Deals & Alliances Report Product Code: LSA03876 | Feb 2008 | £300.00 | 100 % |
| Poniard Pharmaceuticals Inc -Financial Company Report Product Code: LSA04958 | Feb 2008 | £175.00 | 100 % |
| Poniard Pharmaceuticals, Inc. Wright Investors' Service Research Report Product Code: WRT07769 | Jun 2008 | £55.00 | 100 % |
| Poniard Pharmaceuticals Inc Premium Company Profile Product Code: DAT11504 | Apr 2008 | £265.00 | 100 % |
| Cancer Diagnostic Testing World Markets Product Code: TRI00005 | Apr 2008 | £1,970.00 | 20 % |
| Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma Limited R&D activity provides opportunity for early-phase pipeline drugs Product Code: DAT04654 | Mar 2007 | £2,000.00 | 20 % |
| Pipeline Insight: Cancer Overview Increasing Diversity Offers Both High Risk And Reward Product Code: DAT08935 | Sep 2007 | £7,600.00 | 20 % |